Radiation Oncologist @ Sunnybrook Odette Cancer Centre, father, husband, wine snob. Tweets and opinions my own.
Joined November 2012
- Tweets3.3K
- Following1.1K
- Followers1.5K
- Likes4.9K
Danny Vesprini retweeted
Great to see our @Sunnybrook H&N #radonc clinical specialist radiation therapist (CSRT) highlighted in @AdvPracticeRT newsletter. Jeeun An is a star w/ creativity & motivated to further skills w/ ongoing graduate training & help us build the future in adaptive H&N RT and AI.
Just in time for Medical Radiation Technologists (MRT) Week in Canada, we're pleased to share the latest edition of IMPACT: Perspectives in Advanced Practice Radiation Therapy!
canva.com/design/DAHXb7uCalE…
Danny Vesprini retweeted
Congratulations to Jay Detsky, Constantin Schorling & Ying Zhang, winners of our clinical, technical & young investigator abstract awards. Their work in CTV margin de-escalation in glioblastoma MRgRT, MLC tracking & workflow predictability continues to push the boundaries of RT
Danny Vesprini retweeted
Another paradigm shift in radiotherapy #mrlinacconsortium -the future of radiotherapy is “direct to treatment”
aka simulation-free. Why spend weeks creating a plan on anatomy that will change before treatment? @mr_linac
Danny Vesprini retweeted
Now in @JAMAOnc:
We report 5y outcomes post 30 Gy elective RT (total 70 Gy CCRT) for 276 pts w/ HPV-related OPC #hncsm at @MSKCancerCenter #radonc
LRC 97.0%
OS 90.8%
PFS 85.9%
DMFS 91.2%
@imrtlee @xrtGenomics @seanmmcbride @CJTsaiMDPhD @EChrisDee
👉 shorturl.at/liqpP
Danny Vesprini retweeted
Award winning abstract and presentation @IUCS #IUCS26 by @DrSACooper Prostate swelling occurs during radiotherapy but standard SBRT margins are enough to cover this in most patients. Great work 👏@royalmarsdenNHS
Danny Vesprini retweeted
Want to learn or improve your prostate contouring? Who doesn’t!
Registration now open for the @ESTRO_RT Prostate contouring course with me and @dr_vesi 1st and 15th October. estro.org/Courses/2026-Falco…
Danny Vesprini retweeted
#ESTRO26 - 📣 FASTRACKII final results, median F/U of 5 years. Thank you patients, funders, investigators - #kidneycancer #kcsm
1) 100% Local Control: No local recurrences were observed at 36, 60, or 84 months.
2) 100% Cancer-Specific Survival
3) Grade 3 AEs remain at 10%
Danny Vesprini retweeted
One of the standout talks of #ESTRO2026 👏 'A lot to be proud of'
@alison_tree brilliantly highlighted how modern #RadOnc in #PCa is evolving beyond technology alone , with increasing focus on continenze, sexual function and QoL alongside outstanding cancer control!
Danny Vesprini retweeted
Yesterday, I presented the @GETUG_Unicancer PEACE 2 trial at #ESTRO26 on the role of pelvic RT in very high risk #prostatecancer pts (staged with conventional imaging).
Twittorial below
Key conclusion: pelvic RT did not improve clinical outcomes (cPFS, MFS, PCSS, OS)...
1/n
Danny Vesprini retweeted
Great presentation from @DrSACooper on the DESTINATION 1 trial - dose escalation to GTV and simultaneously de-escalating rest of gland appears to have similar adverse events to PACE B. Thanks to collaborators @MOMENTUM_study @dr_vesi @royalmarsdenNHS Uulke van der Heide
Danny Vesprini retweeted
Great debate @ESTRO_RT - do we need augmented/adaptive radiotherapy for prostate cancer? @CZamboglou @DrAndrewLoblaw @valefacc22 and Adam
Mitchell @royalmarsdenNHS Good points made by both sides, but if we can do better, surely we should?
Danny Vesprini retweeted
This morning at #ESTRO26 our incredible rad onc fellow Dr Suman Ghosh @Suman_radonc gave a plenary oral digging deep into the inclusion/omission of FLAIR signal from the UNITED study. Well done Suman!
Danny Vesprini retweeted
Great to welcome such fantastic honorary members at ESTRO2026 @ESTRO_RT including @EmmaHall71 @drdavidpalma @ldawsonmd
Danny Vesprini retweeted
The medical community has a perception that breast cancer screening GOOD and prostate cancer screening BAD. Internist Gil Welch provides data showing just how flawed that perception is.
Danny Vesprini retweeted
Excited to share our publication in @TheLancetOncol on the primary results from the UNITED study: a new paradigm in radiotherapy for patients with glioblastoma /1 @Sunnybrook @UofTDRO thelancet.com/journals/lanon…
Danny Vesprini retweeted
🔎 Ooooo... what's this about a randomised, two-fraction SBRT, federated trial for localised prostate cancer? ☕
🧐What even is a federated trial?
Come and find out more in @BMJ_Open 👇link in comments
#ClinicalTrials #Radiotherapy @alison_tree @dr_vesi Uulke van der Heide
Danny Vesprini retweeted
Curious about whether #SBRT or #brachy is better treatment for intermediate risk prostate cancer?
See @cristian_udo @JAMANetworkOpen article just posted!
JAMANetworkOpen.2026;9(2):e260146. doi:10.1001/jamanetworkopen.2026.0146
@DrSpratticus @AmarUKishan @nickva1 @alison_tree
Danny Vesprini retweeted
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT - Clinical and Translational Radiation Oncology ctro.science/article/S2405-6…
Danny Vesprini retweeted
Great questions! We are testing whole gland de-escalation, maintenance of dose to GTV, in the DESTINATION 1 and 2 trials @dr_vesi @Xristodouleas @mr_linac PSA control higher at 5 years in PACE cf HYPO, but higher risk pts in latter. GU005 will be instructive in due course #pcsm
Danny Vesprini retweeted
Join myself, @gliomadoc @DrNirLipsman and others in support of @icrf_toronto to learn about incredible advances in brain tumor treatments happening here in Toronto, on Wednesday Feb 25th.
icrf.crowdchange.ca/128060
